Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Matthes

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Leukemia|March 1, 2016
Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 studyF Lacombe, E Bernal, D Bloxham, et al.
Investigative Ophthalmology & Visual Science|March 13, 2012
Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS ratsWen-Tao Deng, Astra Dinculescu, Qiuhong Li, et al.
Nature Communications|March 6, 2024
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myelomaC Grandclément, C Estoppey, E Dheilly, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Leukemia|March 1, 2016
Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 studyF Lacombe, E Bernal, D Bloxham, et al.
Investigative Ophthalmology & Visual Science|March 13, 2012
Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS ratsWen-Tao Deng, Astra Dinculescu, Qiuhong Li, et al.
Nature Communications|March 6, 2024
Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myelomaC Grandclément, C Estoppey, E Dheilly, et al.
Pageof 10